Renal and hemodynamic effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction in DELIVER

被引:0
|
作者
Chatur, Safia [1 ]
Cunningham, J. W. [1 ]
Vaduganathan, M. [1 ]
Claggett, B. [1 ]
Desai, A. S. [1 ]
Jhund, P. S. [2 ]
De Boer, R. A. [3 ]
Hernandez, A. F. [4 ]
Inzucchi, S. E. [5 ]
Kosiborod, M. N. [6 ]
Lam, C. S. P. [7 ]
Martinez, F. A. [8 ]
Shah, S. J. [9 ]
Mc Murray, J. J. V. [2 ]
Solomon, S. D. [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] Duke Univ, Med Ctr, Durham, NC USA
[5] Yale Sch Med, New Haven, CT USA
[6] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[7] Natl Heart Ctr Singapore, Singapore, Singapore
[8] Univ Nacl Cordoba, Cordoba, Argentina
[9] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:38 / 39
页数:2
相关论文
共 50 条
  • [21] Dapagliflozin reduces loop diuretic requirement over time in patients with heart failure with mildly reduced or preserved ejection fraction in the DELIVER Trial
    Chatur, Safia
    Vaduganathan, M.
    Claggett, B.
    Vardeny, O.
    Desai, A. S.
    Jhund, P. S.
    De Boer, R. A.
    Lam, C. S. P.
    Kosiborod, M. N.
    Shah, S. J.
    Martinez, F.
    Inzucchi, S. E.
    Hernandez, A. F.
    Mc Murray, J. J. V.
    Solomon, S. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 39 - 40
  • [22] Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction A Prespecified Analysis of the DELIVER Randomized Clinical Trial
    Mc Causland, Finnian R.
    Claggett, Brian L.
    Vaduganathan, Muthiah
    Desai, Akshay S.
    Jhund, Pardeep
    de Boer, Rudolf A.
    Docherty, Kieran
    Fang, James
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Saraiva, Jose F. Kerr
    McGrath, Martina M.
    Shah, Sanjiv J.
    Verma, Subodh
    Langkilde, Anna Maria
    Petersson, Magnus
    McMurray, John J., V
    Solomon, Scott D.
    JAMA CARDIOLOGY, 2023, 8 (01) : 56 - 65
  • [23] Epidemiology and clinical characteristics of hospitalized patients with heart failure with reduced, mildly reduced, and preserved ejection fraction
    Rywik, Tomasz M.
    Dorynska, Agnieszka
    Wisniewska, Anna
    Ceglowska, Urszula
    Drohomirecka, Anna
    Topor-Madry, Roman
    Lazarczyk, Hubert
    Polaska, Paula
    Leszek, Przemyslaw
    Zielinski, Tomasz
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2022, 132 (05):
  • [24] Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
    Ostrominski, John W.
    Thierer, Jorge
    Claggett, Brian L.
    Miao, Zi Michael
    Desai, Akshay S.
    Jhund, Pardeep S.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Inzucchi, Silvio E.
    Martinez, Felipe A.
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Shah, Sanjiv J.
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J. V.
    Solomon, Scott D.
    Vaduganathan, Muthiah
    JACC-HEART FAILURE, 2023, 11 (11) : 1491 - 1503
  • [25] Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial
    Chatur, Safia
    Vaduganathan, Muthiah
    Claggett, Brian
    Solomon, Scott D.
    CIRCULATION, 2024, 150 (06) : e107 - e108
  • [26] Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial
    Chatur, Safia
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Cunningham, Jonathan W.
    Docherty, Kieran F.
    Desai, Akshay S.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe A.
    Shah, Sanjiv J.
    Petersson, Magnus
    Langkilde, Anna Maria
    Mcmurray, John J. V.
    Solomon, Scott D.
    CIRCULATION, 2023, 148 (22) : 1735 - 1745
  • [27] DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN FOR HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION
    Arbel, Ronen
    Oberoi, Mansi
    Alnsasra, Hilmi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 628 - 628
  • [28] Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction
    Arbel, Ronen
    Azab, Abed N.
    Oberoi, Mansi
    Aboalhasan, Enis
    Star, Artyom
    Elhaj, Khaled
    Khalil, Fouad
    Alnsasra, Hilmi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [29] Effect of dapagliflozin on individual components of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
    Peikert, A.
    Chandra, A.
    Vaduganathan, M.
    Kosiborod, M. N.
    Claggett, B. L.
    Desai, A. S.
    Jhund, P. S.
    Lam, C. S. P.
    Inzucchi, S. E.
    Martinez, F. A.
    De Boer, R. A.
    Hernandez, A. F.
    Shah, S. J.
    Mcmurray, J. J. V.
    Solomon, S. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 172 - 172
  • [30] Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER
    Butt, Jawad H.
    Lu, Henri
    Kondo, Toru
    Bachus, Erasmus
    de Boer, Rudolf A.
    Inzucchi, Silvio E.
    Jhund, Pardeep S.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe A.
    Vaduganathan, Muthiah
    Solomon, Scott D.
    Mcmurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, : 2078 - 2090